[Chemotherapy for brain tumor].
Takahashi
Hideaki
H
Department of Neurosurgery, Brain Research Institute, Niigata University.
Tanaka
Ryuichi
R
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D001254:Astrocytoma / Q000188:drug therapy*; D001932:Brain Neoplasms / Q000188:drug therapy*; D016503:Drug Delivery Systems; D005047:Etoposide; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008527:Medulloblastoma / Q000188:drug therapy*; D008727:Methotrexate; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy; D015376:Nimustine; D009837:Oligodendroglioma / Q000188:drug therapy*; D017671:Platinum Compounds; D016032:Randomized Controlled Trials as Topic; D014750:Vincristine
D000970:Antineoplastic Agents; D017671:Platinum Compounds; D015376:Nimustine; D014750:Vincristine; D005047:Etoposide; D008727:Methotrexate